National HealthCare Corporation (NHC) Stock Price & How to Invest

National HealthCare Corporation runs senior health care under one roof: as of August 2026 its affiliates operate 80 skilled nursing facilities with 10,323 licensed beds, 26 assisted living communities with 1,413 units, nine independent living communities with 775 units, three behavioral health hospitals, 34 homecare agencies and 33 hospice agencies, spread across nine states and concentrated in the Southeast. The company reports in two segments, inpatient services and homecare and hospice, and adds smaller lines in pharmacy, rehabilitation therapy, captive insurance and management and accounting services sold to third-party post-acute operators. Founded in Murfreesboro, Tennessee and listed since the 1980s, NHC describes itself as the nation's oldest publicly traded senior care company, and it remains unusually small in share count at roughly 15.7 million shares outstanding.

The investment picture in 2026 turns on two transactions. On June 1, NHC bought five skilled nursing facilities with 639 beds from affiliate National Health Corporation for $50.5 million, and on July 1 it closed a much larger $560 million purchase of 32 skilled nursing facilities and three independent living communities from landlord National Health Investors, terminating the master lease that had governed those buildings. Funding came from a new $550 million credit agreement (a $475 million senior unsecured term loan plus a $75 million revolver), which converts a company that carried essentially no long-term debt at June 30 into a leveraged owner of its own real estate. Revenue reached roughly $1.56 billion on a trailing twelve-month basis, the quarterly dividend was raised to 67 cents, and the shares traded near $228 in mid-August 2026 against a 52-week range of about $107 to $233.

Roughly 29% of net patient revenue comes from Medicaid, and the 2025 federal reconciliation law tightens state provider-tax financing beginning in fiscal 2028, which could squeeze the state rates that fund those beds. Labor is the dominant cost line, with salaries, wages and benefits of about $242 million against $408 million of second-quarter revenue, so nursing wage inflation and agency staffing flow almost directly to margin. Federal minimum-staffing requirements for skilled nursing facilities have been contested in court and in Congress, and a reinstated mandate would raise costs materially. NHC is self-insured for patient-care liability through a wholly owned captive, carries about $121 million of accrued risk reserves, and discloses ordinary-course negligence and patient-care claims that can produce large settlements regardless of outcome; no securities class action is disclosed. Two structural points deserve attention: the company now carries floating-rate debt priced at Term SOFR plus 1.25% to 1.75% where it previously had almost none, and with only about 15.7 million shares outstanding and daily volume near 100,000 shares, the stock is thinly traded and has already roughly doubled off its 52-week low.

We give no verdict on National HealthCare Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Owning the buildings instead of renting them. The $560 million NHI purchase that closed July 1, 2026 moved 32 skilled nursing facilities and three independent living communities onto NHC's own balance sheet and ended the lease that covered them.

The case against. Roughly 29% of net patient revenue comes from Medicaid, and the 2025 federal reconciliation law tightens state provider-tax financing beginning in fiscal 2028, which could squeeze the state rates that fund those beds.

Read the full bull and bear case on NHC, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see National HealthCare Corporation's investor relations page or your broker.

• Revenue (TTM): ~$1.56B
• Q2 2026 revenue: ~$408M (+8.8% YoY)
• Q2 2026 diluted EPS: ~$2.54 GAAP, ~$1.74 adjusted
• Market cap: ~$3.57B (~$228 per share)
• P/E (TTM): ~25x
• Dividend: ~$0.67 quarterly (~1.2% yield)

Second-quarter GAAP results were flattered by items that do not repeat: an $18.3 million catch-up of management fees recognized when the affiliate acquisition closed, plus mark-to-market gains on the securities portfolio. Adjusted net income of about $27.6 million, up 7.2% year over year, is the cleaner read on operations, and the gap between $2.54 GAAP and $1.74 adjusted diluted EPS shows how much noise the equity portfolio introduces. Trailing multiples also predate the July 1 NHI closing, so they reflect a rent-paying, debt-free company rather than the property-owning, leveraged one that exists today.

If you want NHC exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

Other names that sit close to NHC: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get NHC exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (SDVY), which spreads the position across many companies. Or build it into a focused thematic portfolio, so NHC sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where NHC fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

NHC combines a defensive, demographics-backed care business with a balance sheet that went from debt-free to carrying a $475 million term loan in a single quarter, at a price that already reflects a year of doubling.

Whether NHC is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is NHC a buy or a sell?, and where the stock could go from here in the NHC stock forecast.

For income investors, whether NHC pays a dividend and how the payout looks is covered in does NHC pay a dividend? And to weigh NHC against a peer, read the full side-by-side comparisons: NHC vs ENSG and NHC vs BKD.